PyInvesting

Market research

300244.SHE Dian Diagnostics Group Co.,Ltd

SHE CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
13B
P/E ratio
46.93
Analyst target
19.2433
Dividend yield
1.7%
Beta
0.7

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Dian Diagnostics Group Co.,Ltd is currently in a long term downtrend where the price is trading 8.2% below its 200 day moving average.

From a valuation standpoint, the stock is 76.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.

Dian Diagnostics Group Co.,Ltd's total revenue rose by 35.4% to $3B since the same quarter in the previous year.

Its net income has increased by 283.5% to $398M since the same quarter in the previous year.

Finally, its free cash flow grew by 179.6% to $289M since the same quarter in the previous year.

Based on the above factors, Dian Diagnostics Group Co.,Ltd gets an overall score of 4/5.